adg-126
adagene
['adagene']
#icymi: we published interim data for our masked, anti-ctla-4 program, adg126, at #asco. results from 16 patients in a monotherapy dose escalation show a compelling safety profile and antitumor activity. read the summary here: 
Redefining the design and discovery of therapeutic antibodies #LifeIsMotion